Use of Allurion Technologies’ Elipse gastric balloon results in successful weight loss: 4 things to know

New research shows Allurion Technologies’ Elipse balloon is a safe and effective procedureless weight-loss treatment, according to Science Daily.

Advertisement

Researchers presented the data at the European Obesity Summit in Gothenburg, Sweden, from June 1 to June 4.

For the study, 34 patients swallowed one Elipse balloon device, which was filled with 550ml of filling fluid. Allurion designed each balloon to remain in the stomach for four months and then be excreted naturally. The 34 participants had a mean BMI of 34.4 kg/m2.

Here are four things to know:

1. At four months, the mean weight loss was 10 kg or 22 pounds approximately.

2. The total body weight loss percentage was 9.5 percent, and excess weight loss percentage was 37.2 percent.

3. The study also shows improvements in triglycerides and levels of bad cholesterol.

4. Around 90 percent of study participants reported satisfaction with the procedure.

More articles on GI/endoscopy:
5 most read GI/endoscopy stories: June 6 — June 10
Gastroenterologist to know: Dr. Themistocles Dassopoulos of Baylor University Medical Center
Dr. Nader Dbouk joins Atlanta Gastroenterology Associates: 4 points

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

  • Premier Health Partners has acquired Dayton, Ohio-based Digestive Specialists, according to a notice posted on the website of law firm…

Advertisement

Comments are closed.